Advertisement

Topics

Latest "Approves Cardio Revolutionary Diagnostic Heart Device" News Stories

11:12 EST 19th February 2018 | BioPortfolio

Here are the most relevant search results for "Approves Cardio Revolutionary Diagnostic Heart Device" found in our extensive news archives from over 250 global news sources.

More Information about Approves Cardio Revolutionary Diagnostic Heart Device on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Approves Cardio Revolutionary Diagnostic Heart Device for you to read. Along with our medical data and news we also list Approves Cardio Revolutionary Diagnostic Heart Device Clinical Trials, which are updated daily. BioPortfolio also has a large database of Approves Cardio Revolutionary Diagnostic Heart Device Companies for you to search.

Showing "Approves Cardio Revolutionary Diagnostic Heart Device" News Articles 1–25 of 11,000+

Monday 19th February 2018

Key Findings of the Global Allergy Diagnostics Market - Technavio

The latest market research report by Technavio on the global allergy diagnostics market predicts a CAGR


Children International Tests New Mental Health Curriculum

Children International has partnered with Turning Point: A Community Resource of The University of Kansas Health System to implement a curriculum that teaches kids how to be resilient and maintain good mental health. KANSAS CITY, Miss. (PRWEB) February 19, 2018 Depression, anxiety and stress are issues that can affect anyone regardless of their socioeconomic status. However, kids in poverty are p...

Nexxt Spine Marks 250th Implantation of the NEXXT MATRIXX® System Interbody

Nexxt Spine, LLC, a medical device company focused on designing, manufacturing, and distributing innovative spinal solutions, today announced the milestone of the 250th implantation of the NEXXT MATRIXX® System. Launched in 2017 the NEXXT MATRIXX® System is a collection of 3D printed porous titanium interbodies that leverages Nexxt generation te...


Drive for new innovation in General Practice boosted by £8.7 Million from SBRI Healthcare

Ten novel technologies that could revolutionise future primary care and GP services receive further development support 19 February 2018: SBRI Healthcare, the NHS England initiative championed by 15 Academic Health Science Networks, today announced the companies that will benefit from £8.7 million investment to help develop novel technologies aimed at future-proofing primary care and...

Mynosys Cellular Devices Inc. Receives Import Authority From South Korea for Zepto®

Mynosys Cellular Devices Inc. receives import authority from South Korea and announces Zepto® entry into the South Korean market FREMONT, Calif. (PRWEB) February 19, 2018 Mynosys Cellular Devices is pleased to announce that it has received a Medical Device Import Certificate from the South Korean Ministry of Food and Drug Safety for its flagship automated capsulotomy product, Zepto®. ...

E.M.M.A. International Welcomes Ed Potoczak as Director of Sales – EQMS

Mr. Potoczak Brings 30 Years of Experience in Engineering, Sales, Quality Planning, and More FARMINGTON HILLS, Mich. (PRWEB) February 19, 2018 E.M.M.A. International Consulting Group, Inc., a global leader in FDA Compliance consulting, welcomes Ed Potoczak as their Director of Sales – EQMS. Mr. Potoczak will lead the sales of QualiPro, a software solution exclusively offered by E.M.M.A. Interna...

Dr. Matt Ahrens, Experienced Orthodontist, Invites Patients to Discover the Clear Benefits of Invisalign® in Gibsonton, FL

A passionate orthodontist with a history of credentials and heart for volunteerism, Dr. Matt Ahrens consistently helps patients achieve dream smiles through Invisalign® in Gibsonton, FL. Dr. Ahrens now welcomes new patients for Invisalign orthodontics, with or without a referral. GIBSONTON, Fla. (PRWEB) February 19, 2018 Orthodontist, Dr. Matt Ahrens, now invites new patients in and around G...

3D Signatures Inc DXD Medical Equipment Deals and Alliances Profile [Report Updated: 09022018] Prices from USD $250

Summary3D Signatures Inc 3D Signatures is a developer of diagnostic and prognostic products for cancers and neurological disorders. The company's pipeline products comprise 3D TeloPC, a tool which is used to treat prostate cancer. It also offers 3D TeloRS, a diagnostic and prognostic tool used for the treatment of Hodgkin's Lymphoma. 3D Signatures develops diagnostic and prognostic products which ...

Global and North America Colposcopy Market Status and Future Forecast 20132023 [Report Updated: 08022018] Prices from USD $2500

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPart 3:North America Market by company, Type, Application RegionPart 46:Key Regions of North America Market by Type, ApplicationPart 7:Company information, Sales, Cost, Margin etc.Part 8:ConclusionMarke...

Breakthrough in search for diagnostic test for autism

New tests that focus on damage to proteins in blood plasma could indicate autism in children, according to UK researchers, who say their breakthrough could lead to earlier diagnosis.

FDA approves crucial new indication for Imfinzi

The US Food and Drug Administration on Friday approved immuno-oncology drug Imfinzi (durvalumab) for…

20152023 World Monocrystalline Diamond Market Research Report by Product Type, EndUser / Application and Regions / Countries [Report Updated: 01072017] Prices from USD $2800

SummaryThis report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.Market Segment as follows:By Region / Countries North America U.S., Canada, Mexico Europe Germany, U.K., France, Italy, Russia, Spain etc South Americ...

US FDA approves durvalumab for unresectable stage III NSCLC

Tthe US Food and Drug Administration (FDA) has approved durvalumab for the treatment of patients with unresectable Stage III non-small cell lung cancer (NSCLC) whose disease has not progressed following concurrent platinum-based chemotherapy and radiation...

Synergia raises €8.1 million in Series A

Synergia raises €8.1 million in Series A - Novel opto-electronic neurostimulation device in final testing prior to CE mark submission - - Board strengthened with appointments of Reinhard Krickl as Chairman, and Guy Heynen MD and Pierre Detrixhe - Mont-Saint-Guibert, Belgium, 19 February 2018: Synergia Medical SA ("Synergia" or the "Company"), an opto-electro...

GeneNews Ltd GEN Medical Equipment Deals and Alliances Profile [Report Updated: 08022018] Prices from USD $250

SummaryGeneNews Ltd GeneNews is a cancer solution providing company that offers molecular diagnostic products. The company develops and commercializes diagnostics and personalized medicine for cancer and other chronic diseases. Its Sentinel Principle is a novel approach to identifying biomarkers of body state using blood. GeneNews offers biomarkers for detect disease, stage diseases, monitor and p...

Myocarditis Pipeline Review, H1 2018 [Report Updated: 13022018] Prices from USD $2000

Myocarditis Pipeline Review, H1 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myocarditis Pipeline Review, H1 2018, provides an overview of the Myocarditis Cardiovascular pipeline landscape.Myocarditis is inflammation of the heart muscle. Myocarditis is an uncommon disorder that is usually caused by viral, bacterial, or fungal infections that reac...

FDA approves Photocure's new drug and device combination to detect bladder cancer

Norway-based Photocure has secured approval from the US Food and Drug Administration (FDA) for new drug and device combination to detect bladder cancer.

Rapid rise in nitric oxide increases heart attack risk

There is longstanding evidence that the presence of high levels of air pollutants in the atmosphere in particular nitrogen oxides are harmful to health causing respiratory problems and increasing the risk of a heart attack. In a current study published in the European Journal of Preventive Cardiolog...

Best Cure Health System (BCHS), in Partnership with Best Cure Foundation (BCF), TeamBest Companies, and Best Cure Insurance (BCI) is Launching a New Revolutionary, Non-Profit Healthcare Delivery Program

BCHS will establish a global network of 500 plus Cyclotrons (15 MeV to 70 MeV) and Radiopharmaceutical Clinics with full-fledged Diagnostic Radiology Centers as part of BCHS Delivery Network. These Medical and Diagnostic Centers will operate 24/7, and offer care at lower than normal charges, including significantly reduced co-pays for patients, in...

Flowonix Medical Inc Medical Equipment Deals and Alliances Profile [Report Updated: 08022018] Prices from USD $250

SummaryFlowonix Medical Inc Flowonix, formerly Medasys Inc is a medical device company that designs and manufactures implantable drug pump to deliver therapeutic drugs into the spine to relieve chronic disorders. The company's products include prometra pump, catheter, and accessories and programmer. Its accessories and programmers comprise refill kit and catheter access kit and prometra programmer...

Global Microbiome Sequencing Services Market - Rise in Chronic and Infectious Diseases to Boost Growth | Technavio

Technavio market research analysts forecast the global microbiome sequencing services market

Sunday 18th February 2018

Corpak MedSystems Inc Medical Equipment Deals and Alliances Profile [Report Updated: 08022018] Prices from USD $250

SummaryCorpak MedSystems Inc Corpak, a subsidiary of Halyard Health Inc is a medical device company that manufactures and markets enteral feeding safety devices. The company offers products such as cortrak systems, gastrostomy, nasoenteric systems, gastric decompression, NICU products and accessories. Its accessories include ACE stoppers, adaptor repair kits, clog zappers, extension set, tube rete...

Itamar Medical Ltd ITMR Medical Equipment Deals and Alliances Profile [Report Updated: 08022018] Prices from USD $250

SummaryItamar Medical Ltd Itamar Medical is a medical device company that offers biomedical technology products. The company develops, markets and distributes diagnostic medical devices. Its products include EndoPAT, a medical device for the diagnosis of endothelial dysfunction; and WatchPAT, a diagnostic device which provides accurate screening, detection, and diagnosis of sleep apnea and sleep d...

Insight Genetics Inc Medical Equipment Deals and Alliances Profile [Report Updated: 08022018] Prices from USD $250

SummaryInsight Genetics Inc Insight Genetics is a molecular diagnostic company that discovers, develops and commercializes companion diagnostics. The company offers products which include ROS1, RET fusions and for lung cancer and ALK for breast cancer. It provides cancer testing services to oncologists and pharmaceutical companies. Insight Genetics offer services which include companion diagnostic...

FDA approves first treatment to reduce risk of NSCLC progression

The U.S. Food and Drug Administration today approved Imfinzi (durvalumab) for the treatment of patients with stage III non-small cell lung cancer (NSCLC) whose tumors are not able to be surgically removed (unresectable) and whose cancer has not progressed after treatment with chemotherapy and radiation (chemoradiation).


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks